Statins in Aortic Disease

Author(s): Vasiliki Tsigkou , Gerasimos Siasos* , Evanthia Bletsa , Maria-Paraskevi Panoilia , Angeliki Papastavrou , Georgios Kokosias , Evangelos Oikonomou , Marina Zaromitidou , Manolis Vavuranakis , Christodoulos Stefanadis , Dimitris Tousoulis .

Journal Name: Current Pharmaceutical Design

Volume 23 , Issue 46 , 2017

Abstract:

Background: Numerous studies indicate that statins have multiple beneficial actions (known as ‘pleiotropic actions') on cardiovascular system through the improvement of endothelial dysfunction, inflammation, oxidative stress, excessive arterial thrombosis, and stabilization of the atherosclerotic plaque. Aortic disease primarily consists of aortic valve stenosis, aortic valve regurgitation, aneurysm disease, and genetic disorders such as Marfan syndrome, bicuspid aortic valve and aortic coarctation. Many studies have revealed the cardioprotective actions of statins in aortic disease.

Objective: Our aim was to present current data concerning the value of treatment with statins in aortic diseases.

Methods: A thorough search of PubMed and the Cochrane Database was conducted to identify the studies and novel articles related to the use of statins in aortic disease.

Results: Numerous studies in animals and humans indicate a beneficial effect of treatment with statins in the previous conditions apart from a few conflicting data.

Conclusion: There is a need of further investigation in this field, especially for the estimation of the optimal type and dose of statins required in each clinical condition of aortic disease.

Keywords: Aortic disease, cardiovascular diseases, HMG-CoA- inhibitors, inflammation, statins, endothelial dysfunction.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 23
ISSUE: 46
Year: 2017
Page: [7109 - 7120]
Pages: 12
DOI: 10.2174/1381612823666171115100829
Price: $58

Article Metrics

PDF: 22
HTML: 1
EPUB: 1